U.S.–WHO Split Deepens as Tedros Rejects Washington’s Claims and Warns of Global Health Risks
The United States has formally completed its exit from the World Health Organization, marking a major turning point in global health diplomacy. The withdrawal became official on January 22, 2026, exactly one year after President Donald Trump signed the executive order initiating the departure. Within days, the move triggered a strong and detailed response from the WHO’s leadership.
On January 24 and 25, WHO Director-General Dr. Tedros Adhanom Ghebreyesus publicly challenged the U.S. government’s justification for leaving the agency, calling several of its claims “untrue” and cautioning that the decision weakens international health security.
WHO Pushes Back on Pandemic Accusations
Addressing criticism over the handling of COVID-19, Tedros firmly denied allegations that the organization concealed information or delayed warnings during the pandemic. He stated that the WHO shared scientific findings and risk assessments as quickly as they became available, stressing that transparency remained a priority throughout the crisis.
Tedros also addressed long-standing claims that the WHO imposed health restrictions on countries. According to him, the organization never enforced lockdowns, mask rules, or vaccination requirements. Instead, it issued non-binding guidance, leaving each government free to decide how to respond based on national conditions.
Despite the breakdown in relations, Tedros struck a conciliatory tone by expressing hope that the United States might eventually rejoin the organization. He emphasized that infectious diseases do not respect borders and that global cooperation is essential to prevent future health emergencies.
Washington Defends Exit on Sovereignty Grounds
U.S. officials, including Secretary of State Marco Rubio and Health Secretary Robert F. Kennedy Jr., defended the withdrawal as a necessary step to protect American decision-making authority. They argued that the WHO failed to properly investigate China’s role in the early stages of the COVID-19 outbreak and circulated flawed information that influenced global responses.
The administration also portrayed the WHO as structurally inefficient, accusing it of resisting reforms related to transparency and accountability. Another major concern cited was funding. U.S. officials claimed American taxpayers were contributing a disproportionately large share of the WHO’s budget, estimated at 15 to 20 percent, while rival powers contributed far less.
Legal Dispute Over Exit and Unpaid Contributions
The separation is further complicated by unresolved legal and financial questions. Under WHO regulations dating back to 1948, a member state must clear all outstanding financial obligations before its withdrawal can be finalized.
The WHO maintains that the United States still owes between $260 million and $280 million in unpaid contributions for 2024 and 2025. The Trump administration has indicated it does not plan to settle these dues, arguing that the withdrawal notification is sufficient.
These conflicting interpretations will be reviewed by the WHO Executive Board, which is scheduled to meet on February 2, 2026. The outcome could shape not only the U.S.–WHO relationship but also set a precedent for how future withdrawals are handled.
As the debate continues, the split highlights a growing tension between national sovereignty and global cooperation — a question likely to influence international health policy for years to come.
